Natixis Advisors’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,046
| Closed | -$255K | – | 1323 |
|
|
2021
Q2 | $255K | Sell |
12,046
-84
| -0.7% | -$1.78K | ﹤0.01% | 1289 |
|
|
2021
Q1 | $340K | Buy |
12,130
+1,908
| +19% | +$53.5K | ﹤0.01% | 1216 |
|
|
2020
Q4 | $266K | Buy |
+10,222
| New | +$266K | ﹤0.01% | 1188 |
|